Journal
CURRENT HYPERTENSION REVIEWS
Volume 19, Issue 2, Pages 123-129Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1573402119666230330082128
Keywords
Amlodipine; nebivolol; valsartan; combination therapy; ambulatory blood pressure; peripheral blood pressure
Categories
Ask authors/readers for more resources
This study compared the antihypertensive effects of two drug combinations in hypertensive patients, and found that both combinations were highly effective in reducing peripheral and 24-hour ambulatory blood pressure. There was no statistically significant difference between the two groups in terms of blood pressure reduction.
Background Nebivolol has a dual mechanism of action, exerting a moderate b- blockade effect and reducing peripheral arterial resistance, as a result, the antihypertensive effect of nebivolol may be higher than that of a potent vasodilator CCB such as amlodipine.Aim The study evaluated the effect of two nebivolol/valsartan on 24 hour ambulatory blood pressure versus amlodipine/valsartan in grade II or III hypertension patients or having uncontrolled BP despite treatment. Ambulatory blood pressure monitoring is a powerful method to monitor the changes in blood pressure over the 24 hour.Materials and Methods A total of 74 from 90 patients continued the study. Fourty patients received amlodipine 10 mg/valsartan 160 mg (group I), and thirty-four patients received nebivolol 5 mg/ valsartan 160 mg (group II). Peripheral blood pressure readings were measured at randomization at 6 and 12 weeks. Ambulatory blood pressure was measured at randomization and 12 weeks.Results Both drug combinations showed high efficacy in reducing peripheral and 24 hour ambulatory BP. There was no statistically significant difference between the groups in lowering peripheral systolic and diastolic blood pressure at 6 and 12 weeks. Furthermore, both groups failed to show any significant difference in reducing 24 hour SBP and DBP. Regarding day SBP, the blood pressure dropped by -5.63 & PLUSMN; 14.87 in group I and -6.25 & PLUSMN; 11.59 in group II (p = 0.844). Also, group I reduced the day DBP average by -2.53 & PLUSMN; 9.83 and group II by -3.61 & PLUSMN; 9.78 (p = 0.640). In addition, both drug combinations had no statistically significant difference in lowering night SBP and DBP average.Conclusion Both treatment groups reached the target ambulatory blood pressure, and there was no statistically significant difference between both groups as a regard reduction in all ambulatory blood pressure readings.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available